← All companies

MOLN

Molecular Partners AG

MOLN Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$4.12

+0.19 +4.83%

Key statistics

from XBRL data in SEC filings

Market cap

$166M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$3.46 – $5.36

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 20, 2026 6-K FORM 6-K Jul 7, 2026 6-K FORM 6-K Jul 2, 2026 6-K FORM 6-K Jun 1, 2026 6-K May 12, 2026 6-K FORM 6-K May 1, 2026 6-K FORM 6-K Apr 14, 2026 6-K Mar 30, 2026 6-K FORM 6-K Mar 13, 2026 6-K Mar 12, 2026 20-F Mar 12, 2026 6-K FORM 6-K Feb 2, 2026 6-K FORM 6-K Jan 12, 2026 6-K FORM 6-K Dec 8, 2025 6-K FORM 6-K Nov 12, 2025 6-K Oct 30, 2025 6-K Aug 25, 2025 6-K Jun 12, 2025 6-K May 15, 2025 6-K Apr 29, 2025 6-K FORM 6-K Mar 6, 2025 6-K Mar 6, 2025 20-F Mar 6, 2025 6-K FORM 6-K Jan 13, 2025 6-K FORM 6-K Jan 13, 2025 6-K Oct 31, 2024 6-K Oct 28, 2024 6-K FORM 6-K Oct 22, 2024 6-K Aug 26, 2024 6-K Jun 14, 2024 6-K FORM 6-K Jun 11, 2024 6-K FORM 6-K Jun 3, 2024 6-K/A May 17, 2024 6-K May 16, 2024 6-K FORM 6-K Mar 26, 2024 20-F Mar 14, 2024 6-K FORM 6-K Jan 8, 2024 6-K FORM 6-K Jan 5, 2024 6-K FORM 6-K Dec 11, 2023 6-K FORM 6-K Nov 2, 2023